News Coverage 10.20.20 Share on Twitter Share on Facebook Share on LinkedIn The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Related Announcement, Press Release Dr. Sager Named Recipient of PICI’s Inaugural YIA Award Announcement, Press Release PICI Brings Power of Integrated Network to ASCO 2026 Announcement, Press Release PICI Welcomes Aimee Johnson as Chief Marketing Officer